Issues with galactomannan testing

References

• Latge JP, Kobayashi H, Debeaupuis JP, Diaquin M, Sarfati J, Wieruszeski JM, Parra E, Bouchara JP, Fournet B. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 1994; 62: 5424–5433
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349–357
   PubMed Web of Science ®Google Scholar
• Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497–500
   PubMed Web of Science ®Google Scholar
• Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, Darras V, Latge JP. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237–2245
   PubMed Web of Science ®Google Scholar
• Verweij, PE, Masson, C, Klont, R, Heinen, C, Crepin, B, Maertens, J. Optimisation of the cut-off value of the Platelia Aspergillus ELISA. 16th European Conference on Clinical Microbiology and Infectious Diseases 2006.
   Google Scholar
• Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000; 355: 423–424
   PubMed Web of Science ®Google Scholar
• Hope W, Walsh T, Denning D. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609–622
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306
   PubMed Web of Science ®Google Scholar
• Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604–1610
   PubMed Web of Science ®Google Scholar
• Morelle W, Bernard M, Debeaupuis J-P, Buitrago M, Tabouret M, Latgé J-P. Galactomannoproteins of Aspergillus fumigatus. Eukaryot Cell 2005; 4: 1308–1316
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MASH, Ruegebrink D, Wasei N, Melchers WJG, Verweij PE. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol. 2006; 44: 1711–1718
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641–649
   PubMed Web of Science ®Google Scholar
• Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762–1769
   PubMed Web of Science ®Google Scholar
• Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998; 26: 1407–1412
   PubMed Web of Science ®Google Scholar
• Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van EJ, Verbist L, Boogaerts M. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223–3228
   PubMed Web of Science ®Google Scholar
• Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, Grillot R. Detection of circulating Aspergillus fumigatus galactomannan: Value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41: 2184–2186
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten, MASH, Ruegebrink, D, Klont, RR, Blijlevens, NMA, Donnelly, JP, Verweij, PE. Improved detection of circulating aspergillus antigen using a new pre-treatment procedure. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, 2005.
   Google Scholar
• Mennink-Kersten, MASH, Ruegebrink, D, Klont, RR, Verweij, PE. Release of galactofuranose antigens by different Aspergillus species. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, 2005. Abstract M-153.
   Google Scholar
• Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232–237
   PubMed Web of Science ®Google Scholar
• Siemann M, Koch-Dorfler M, Gaude M. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998; 41: 373–377
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91: 311–318
   PubMed Web of Science ®Google Scholar
• Gangneux JP, Lavarde D, Bretagne S, Guiguen C, Gandemer V. Transient aspergillus antigenaemia: think of milk. Lancet 2002; 359: 1251
   PubMed Web of Science ®Google Scholar
• Adam O, Aupérin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917–920
   PubMed Web of Science ®Google Scholar
• Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006; 44: 389–394
   PubMed Web of Science ®Google Scholar
• Mattei D, Rapezzi D, Mordini N, Cuda F, Lo Nigro C, Musso M, Arnelli A, Cagnassi S, Gallamini A. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004; 42: 5362–5363
   PubMed Web of Science ®Google Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366–2377
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, Murray H, Mya-San C, Bacher J, Petraitis V. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42: 4744–4748
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913–916
   PubMed Web of Science ®Google Scholar
• Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F, Philippe B, Bossi P, Danis M, Vernant JP, Datry A. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43: 5214–5220
   PubMed Web of Science ®Google Scholar
• Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353–357
   PubMed Web of Science ®Google Scholar
• Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004; 48: 1989–1992
   PubMed Web of Science ®Google Scholar
• Dalle F, Emmanuel Charles P, Blanc K, Caillot D, Chavanet P, Dromer F, Bonnin A. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 2005; 43: 2929–2931
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet 2004; 363: 325–327
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MASH, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJM, Verweij PE. Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005; 43: 3925–3931
   PubMed Web of Science ®Google Scholar
• Maertens J, Glasmacher A, Selleslag D, Ngai A, Ryan D, Layton M, Taylor A, Sable C, Kartsonis N. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. Clin Infect Dis 2005; 41: e9–14
   PubMed Web of Science ®Google Scholar
• Klont R, Mennink-Kersten MASH, Ruegebrink D, et al. Paradoxal rise of circulating Aspergillus antigen in a patient with pulmonary aspergillosis while receiving primary therapy with caspofungin. Clin Infect Dis 2006; 43: e23–5
   Web of Science ®Google Scholar
• Kwak E, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener MM, Singh N. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004; 42: 435–438
   PubMed Web of Science ®Google Scholar
• Weisser M, Rausch C, Droll A, Simcock M, Sendi P, Steffen I, Buitrago C, Sonnet S, Gratwohl A, Passweg J, Fluckiger U. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005; 41: 1143–1149
   PubMed Web of Science ®Google Scholar
• Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computed tomography–based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242–1250
   PubMed Web of Science ®Google Scholar